LONDON (Thomson Financial) - ReGen Therapeutics Plc. said its Colostrinin
protects hippocampal cells in the brain against beta-amyloid and oxidative
stress, according to the findings of a new study. it is confident in promoting
Colostrinin/CogniSure as a nutraceutical for healthy brain ageing.
The company said it is confident in promoting Colostrinin/CogniSure as a
nutraceutical for healthy brain ageing, adding that these findings are very
significant as the hippocampus is one of the key brain areas known to be
affected in neurodegenerative diseases such as Alzheimer's disease.
TFN.newsdesk@thomson.com
rda/ajb
COPYRIGHT
Copyright Thomson Financial News Limited 2008. All rights reserved.
The copying, republication or redistribution of Thomson Financial News Content,
including by framing or similar means, is expressly prohibited without the prior
written consent of Thomson Financial News.
|